Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

evolv technologies - EVLV

EVLV

Close Chg Chg %
2.62 0.30 11.26%

Open Market

2.92

+0.30 (11.26%)

Volume: 1.76M

Last Updated:

Nov 21, 2024, 1:04 PM EDT

Trade Now

Company Overview: evolv technologies - EVLV

EVLV Key Data

Open

$2.70

 Day Range

2.70 - 2.97

52 Week Range

2.01 - 5.72

 Market Cap

$412.78M

Shares Outstanding

157.55M

 Public Float

107.68M

Beta

1.34

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.13

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

3.76M

  

EVLV Performance

1 Week
 
 1.55%
 
1 Month
 
 6.07%
 
3 Months
 
 -35.63%
 
1 Year
 
 -34.50%
 
5 Years
 
 N/A
 

EVLV Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 3
Full Ratings ➔

About evolv technologies - EVLV

Evolv Technologies Holdings, Inc. engages in the manufacture and development of security screening products. It also provides artificial intelligence-based security screening solutions for industries including casinos, industrial workplaces, schools, and ticketed venues. The company was founded by Anil R. Chitkara and Michael Philip Ellenbogen in July 2013 and is headquartered in Waltham, MA.

EVLV At a Glance

Evolv Technologies Holdings, Inc.
500 Totten Pond Road
Waltham, Massachusetts 02451
Phone 1-781-374-8100 Revenue 80.42M
Industry Electronic Equipment/Instruments Net Income -106,254,000.00
Sector Electronic Technology 2023 Sales Growth 45.698%
Fiscal Year-end 12 / 2024 Employees 293
View SEC Filings

EVLV Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 8.755
Price to Book Ratio 4.881
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -7.522
Enterprise Value to Sales 7.296
Total Debt to Enterprise Value 0.002

EVLV Efficiency

Revenue/Employee 274,464.164
Income Per Employee -362,641.638
Receivables Turnover 3.056
Total Asset Turnover 0.249

EVLV Liquidity

Current Ratio 2.143
Quick Ratio 2.027
Cash Ratio 1.447

EVLV Profitability

Gross Margin 42.066
Operating Margin -109.354
Pretax Margin -132.064
Net Margin -132.127
Return on Assets -32.854
Return on Equity -56.926
Return on Total Capital -71.932
Return on Invested Capital -53.952

EVLV Capital Structure

Total Debt to Total Equity 0.951
Total Debt to Total Capital 0.942
Total Debt to Total Assets 0.466
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital N/A
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Evolv Technologies - EVLV

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
- 23.69M 55.20M 80.42M
Sales Growth
- - +132.97% +45.70%
-
Cost of Goods Sold (COGS) incl D&A
- 17.05M 42.99M 46.59M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- 2.90M 6.28M 9.93M
Depreciation
- 2.90M 6.28M 9.93M
Amortization of Intangibles
- - - -
-
COGS Growth
- - +152.12% +8.37%
-
Gross Income
- 6.64M 12.21M 33.83M
Gross Income Growth
- - +83.79% +177.16%
-
Gross Profit Margin
- +28.03% +22.11% +42.07%
2020 2021 2022 2023 5-year trend
SG&A Expense
1.03M 58.83M 103.13M 121.77M
Research & Development
- 11.42M 18.77M 24.45M
Other SG&A
1.03M 47.42M 84.36M 97.31M
SGA Growth
- +5,611.94% +75.29% +18.07%
Other Operating Expense
- - - -
-
Unusual Expense
- (48.05M) (12.61M) 23.75M
EBIT after Unusual Expense
(1.03M) (4.15M) (78.32M) (111.69M)
Non Operating Income/Expense
79.00K (617.00K) 3.10M 6.14M
Non-Operating Interest Income
- 79.00K 3.17M 6.23M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- 6.09M 712.00K 654.00K
Interest Expense Growth
- - -88.32% -8.15%
-
Gross Interest Expense
- 6.09M 712.00K 654.00K
Interest Capitalized
- - - -
-
Pretax Income
(951.00K) (10.86M) (86.41M) (106.20M)
Pretax Income Growth
- -1,041.75% -695.78% -22.91%
Pretax Margin
- -45.83% -156.55% -132.06%
Income Tax
- - - 51.00K
-
Income Tax - Current - Domestic
- - - 27.00K
-
Income Tax - Current - Foreign
- - - 24.00K
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(951.00K) (10.86M) (86.41M) (106.25M)
Minority Interest Expense
- - - -
-
Net Income
(951.00K) (10.86M) (86.41M) (106.25M)
Net Income Growth
- -1,041.75% -695.78% -22.97%
Net Margin Growth
- -45.83% -156.55% -132.13%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(951.00K) (10.86M) (86.41M) (106.25M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(951.00K) (10.86M) (86.41M) (106.25M)
EPS (Basic)
-0.0441 -0.1515 -0.6006 -0.7123
EPS (Basic) Growth
- -243.54% -296.44% -18.60%
Basic Shares Outstanding
21.56M 71.66M 143.86M 149.17M
EPS (Diluted)
-0.0441 -0.1515 -0.6006 -0.7123
EPS (Diluted) Growth
- -243.54% -296.44% -18.60%
Diluted Shares Outstanding
21.56M 71.66M 143.86M 149.17M
EBITDA
(1.03M) (49.30M) (84.65M) (78.01M)
EBITDA Growth
- -4,686.12% -71.71% +7.84%
EBITDA Margin
- -208.07% -153.36% -97.00%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 4.85
Number of Ratings 3 Current Quarters Estimate -0.067
FY Report Date 12 / 2024 Current Year's Estimate -0.267
Last Quarter’s Earnings -0.07 Median PE on CY Estimate N/A
Year Ago Earnings -0.36 Next Fiscal Year Estimate -0.187
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 3 3
Mean Estimate -0.07 -0.06 -0.27 -0.19
High Estimates -0.05 -0.05 -0.26 -0.13
Low Estimate -0.09 -0.08 -0.28 -0.27
Coefficient of Variance -31.23 -28.87 -4.33 -39.49

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 4
OVERWEIGHT 0 0 0
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Evolv Technologies - EVLV

Date Name Shares Transaction Value
Jun 5, 2024 Mark J. Donohue Chief Financial Officer 367,046 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 Mark J. Donohue Chief Financial Officer 467,827 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $2.73 per share 1,277,167.71
Jun 5, 2024 Mark J. Donohue Chief Financial Officer 654,310 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 4, 2024 Neil Glat Director 54,195 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 4, 2024 Kimberly H. Sheehy Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 4, 2024 Kimberly H. Sheehy Director 88,840 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 4, 2024 Kevin M. Charlton Director 54,195 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 4, 2024 Kevin M. Charlton Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 4, 2024 Kevin M. Charlton Director 277,765 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 4, 2024 Kimberly H. Sheehy Director 54,195 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 4, 2024 David Mounts Gonzales Director 70,544 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 4, 2024 Mark J. Sullivan Director 121,123 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 4, 2024 Neil Glat Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 4, 2024 Merline Saintil Director 54,195 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 4, 2024 Merline Saintil Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 4, 2024 David Mounts Gonzales Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 4, 2024 Merline Saintil Director 88,840 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 4, 2024 David Mounts Gonzales Director 54,195 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 4, 2024 Neil Glat Director 154,022 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 4, 2024 Mark J. Sullivan Director 54,195 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Evolv Technologies in the News